US Patent 10525076 Antisense compounds targeting genes associated with cystic fibrosis
Patent 10525076 was granted and assigned to Rosalind Franklin University of Medicine and Science on January, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 8, 2017
0
Date of Patent
January 7, 2020
0
Patent Applicant
Patent Application Number
15835698
0
Patent Inventor Names
Michelle L. Hastings
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10525076 Antisense compounds targeting genes associated with cystic fibrosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.